A Milestone in the Shift from "Passive Killing" to "Active Immunomodulation" in Cancer Treatment—Progress in Melanoma Vaccine Research.

Detalles Bibliográficos
Publicado en:Current Treatment Options in Oncology Vol. 26; no. 8; pp. 688 - 706
Autores principales: Zhang, Yuke, Liu, Jie, Chang, Xiyue, Yang, Xuejing, Zhang, Xinyue, Xiao, Wan'an
Formato: Journal Article
Publicado: Springer Nature Aug2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=188624417&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 188624417
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15272729
        3KHC
      jtl: Current Treatment Options in Oncology
      issn: 15272729
      maglogo: N
    pubinfo:
      dt: Aug2025
      vid: 26
      iid: 8
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        188624417
        186695283
        10.1007/s11864-025-01340-6
        188624417
      ppf: 688
      ppct: 18
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: A Milestone in the Shift from "Passive Killing" to "Active Immunomodulation" in Cancer Treatment—Progress in Melanoma Vaccine Research.
      aug:
        au:
          Zhang, Yuke
          Liu, Jie
          Chang, Xiyue
          Yang, Xuejing
          Zhang, Xinyue
          Xiao, Wan'an
        affil: https://ror.org/0202bj006 Department of Orthopedics, Shengjing Hospital of China Medical University, 36 Sanhao Street, Heping District, 110004, Shenyang, Liaoning, China
      sug:
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N